ACHC · XBRL financial data
Acadia Healthcare Company financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ACHC's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 2,090 | 2,314 | 2,610 | 2,929 | 3,154 | 3,313 |
| General and administrative | 98 | 108 | 124 | 153 | 157 | 178 |
| Income tax expense (benefit) | 41 | 68 | 94 | (10) | 77 | 26 |
| Net income (loss) | (672) | 191 | 273 | (22) | 256 | (1,103) |
| Earnings per share, basic USD per share | (7.65) | 2.15 | 3.05 | (0.24) | 2.79 | (12.16) |
| Earnings per share, diluted USD per share | (7.59) | 2.10 | 2.98 | (0.24) | 2.78 | (12.16) |
| Weighted average shares, basic millions of shares | 88 | 89 | 90 | 91 | 92 | 91 |
| Weighted average shares, diluted millions of shares | 89 | 91 | 92 | 91 | 92 | 91 |
Balance sheet
CSVFiscal years (ACHC's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 379 | 134 | 98 | 100 | 76 | 133 |
| Accounts receivable | 274 | 281 | 322 | 361 | 365 | 441 |
| Inventory | 5 | 5 | 5 | 5 | 6 | 6 |
| Total current assets | 2,523 | 495 | 506 | 596 | 577 | 814 |
| Property and equipment, net | 1,623 | 1,771 | 1,952 | 2,267 | 2,853 | 3,111 |
| Right-of-use asset | 97 | 134 | 135 | 118 | 118 | 134 |
| Goodwill | 2,105 | 2,200 | 2,223 | 2,226 | 2,265 | 1,296 |
| Total assets | 6,499 | 4,768 | 4,988 | 5,359 | 5,957 | 5,527 |
| Accounts payable | 88 | 99 | 105 | 156 | 233 | 150 |
| Current portion of long-term debt | 153 | 19 | 21 | 29 | 77 | 28 |
| Total current liabilities | 1,308 | 405 | 388 | 886 | 578 | 525 |
| Long-term debt | 2,969 | 1,479 | 1,365 | 1,343 | 1,880 | 2,472 |
| Lease liability, non-current | 84 | 117 | 116 | 101 | 102 | 122 |
| Total liabilities | 4,545 | 2,185 | 2,087 | 2,471 | 2,766 | 3,387 |
| Retained earnings (accumulated deficit) | (310) | (120) | 153 | 132 | 387 | (766) |
| Total stockholders' equity | 1,899 | 2,517 | 2,813 | 2,782 | 3,074 | 1,949 |
| Total liabilities and equity | 6,499 | 4,768 | 4,988 | 5,359 | 5,957 | 5,527 |
| Common shares outstanding (cover page) millions of shares | 89 | 90 | 91 | 92 | 93 | 92 |
Cash flows
CSVFiscal years (ACHC's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (672) | 191 | 273 | (22) | 256 | (1,103) |
| Stock-based compensation | 23 | 38 | 30 | 32 | 37 | 32 |
| Net cash from operating activities | 659 | 374 | 381 | 462 | 130 | 132 |
| Purchases of property and equipment | 217 | 245 | 296 | 424 | 690 | 572 |
| Net cash from investing activities | (282) | 1,018 | (306) | (397) | (736) | (556) |
| Share repurchases | — | — | — | — | — | 50 |
| Proceeds from long-term debt | 925 | 425 | — | — | 350 | 1,200 |
| Net cash from financing activities | (51) | (1,641) | (111) | (63) | 583 | 481 |
| Net change in cash | 255 | (245) | (36) | 2 | (24) | 57 |
Compare with peers
SIC 8093 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8093 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Acadia Healthcare Company | 163 | 895 | 98* | 93.0M | 10-QSep 30, 2026 |
| Progyny | 153 | 351 | 50* | 76.7M | 10-QJun 30, 2026 |
| Concentra Group Holdings Parent | 158 | 606 | 135* | 127.5M | 10-QJun 30, 2026 |
| Sotera Health | 412 | 325 | 111* | 285.6M | 10-QSep 30, 2026 |
| agilon health | 174 | 1,519 | 50* | 16.8M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
